http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/ News About Tech, Money and Innovation Wed, 25 Nov 2009 12:19:57 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/comment-page-1/#comment-630576 VentureBeat » Life sciences briefing: Monday, Nov. 12, 2007 Tue, 13 Nov 2007 17:15:50 +0000 http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/#comment-630576 [...] Anaptys relies on a technique for producing large quantities of varied antibodies in order to find ones with the best “drug-like” properties. We’ve written about other companies working on similar “diversity generation” techniques, most recently AvidBiotics, which we described here. [...] [...] Anaptys relies on a technique for producing large quantities of varied antibodies in order to find ones with the best “drug-like” properties. We’ve written about other companies working on similar “diversity generation” techniques, most recently AvidBiotics, which we described here. [...]

]]> http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/comment-page-1/#comment-630324 VentureBeat » Life sciences daily briefing: Monday, Nov. 12, 2007 Tue, 13 Nov 2007 13:12:42 +0000 http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/#comment-630324 [...] Anaptys relies on a technique for producing large quantities of varied antibodies in order to find ones with the best “drug-like” properties. We’ve written about other companies working on similar “diversity generation” techniques, most recently AvidBiotics, which we described here. [...] [...] Anaptys relies on a technique for producing large quantities of varied antibodies in order to find ones with the best “drug-like” properties. We’ve written about other companies working on similar “diversity generation” techniques, most recently AvidBiotics, which we described here. [...]

]]> http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/comment-page-1/#comment-621406 VentureBeat » AvidBiotics raises $1M for anti-infective drugs — Wed, 07 Nov 2007 23:59:37 +0000 http://venturebeat.com/2007/11/05/life-sciences-briefing-monday-nov-5-2007/#comment-621406 [...] our story about this South San Francisco, Calif., biotech in Monday’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story about this South San Francisco, Calif., biotech in Monday’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]>